Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this Phase 1b study is to investigate whether intravenous administration of REOLYSIN® in combination with chemotherapy and pembrolizumab is effective and safe in the treatment of pancreatic adenocarcinoma.
Epistemonikos ID: 0f1e8b68e30346333046dbbf74620e422f8f324f
First added on: May 12, 2024